Encephalitis

Peer review policy

Page Path

HOME
EDITORIAL POLICY
Peer review policy

All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

Double-blind peer review
encephalitis adopts double blind review, which means that the reviewers do not know the identity of the authors, and vice versa.

MOST VIEWED MOST CITED

4,870	Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
5,467	Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma
3,660	Management of convulsive status epilepticus: recent updates
4,125	Lumbar puncture: considerations, procedure, and complications
6,998	Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy

+more

Cited By 2	Chronic social stress during early development elicits unique behavioral changes in adulthood
Cited By 2	Management of convulsive status epilepticus: recent updates
Cited By 2	Protein biomarkers in multiple sclerosis
Cited By 1	Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
Cited By 1	Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid

+more

Editorial Office: 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
Tel: +82-2-2072-0629 Fax: +82-2-765-7920 E-mail: editor@encephalitisjournal.org